Recent City of Hope press releases and you tube (and discussed on the chatline) does suggest "they" view our drug, as the premier GBM T Cell therapy in development at CoH.
So interesting to say the least , what is discussed by Christine tomorrow.
I generally am more interested, or at least weight up, news that comes from these top US hospitals - more so that local management discussion. So a great chance tomorrow night.
Modern biomarker studies, in the last two years - has moved ahead of what smaller biotech punters understand. Highly sophisticated blood, imaging and molecular DNA studies (whereby each and every cancer cell is examined before and after treatment)......mean its not a case anymore if the drug works - rather the ability of clinicians to match the drug with the muted gene.
This is what Christine will talk about tomorrow.
This drug has got such strong endorsement from City, and I think it will reach the market. Listen to the pres and learn.
Keynote Presentation: CAR T Cell Therapy for Glioblastoma: Promise and Challenges
Saturday, November 20, 2021
10:00 AM – 10:30 AM EST
Location: Auditorium
Keynote Speaker(s)
Christine E. Brown, PhD
City of Hope National Medical Center
Duarte, United States
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)